Skip Navigation



Carcinogenesis Advance Access published online on January 6, 2009

Carcinogenesis, doi:10.1093/carcin/bgp006
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
30/3/416    most recent
bgp006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Marsit, C. J.
Right arrow Articles by Kelsey, K. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marsit, C. J.
Right arrow Articles by Kelsey, K. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Epigenetic Profiling Reveals Etiologically Distinct Patterns of DNA Methylation in Head and Neck Squamous Cell Carcinoma

Carmen J. Marsit1,*, Brock C. Christensen1,*, E. Andres Houseman2,9, Margaret R. Karagas3, Margaret R. Wrensch4,5, Ru-Fang Yeh5, Heather H. Nelson6, Joseph L. Wiemels4,5, Shichun Zheng4, Marshall R. Posner7, Michael D. McClean8, John K. Wiencke4 and Karl T. Kelsey1,9

1 Department of Pathology and Laboratory Medicine
9 Department of Community Health Center for Environmental Health and Technology, Brown University, Providence, RI
2 Department of Biostatistics, Harvard School of Public Health, Boston, MA
3 Department of Community and Family Medicine, Dartmouth Medical School, Lebanon, NH
4 Department of Neurological Surgery
5 Department of Epidemiology and Biostatistics, University of California – San Francisco, San Francisco, CA
6 Division of Epidemiology and Community Health, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota
7 Head and Neck Oncology Program, Dana-Farber Cancer Center, Boston, MA
8 Department of Environmental Health, Boston University School of Public Health, Boston, MA

To whom correspondence should be addressed: Carmen J. Marsit, PhD. Department of Pathology and Laboratory Medicine, Brown University, Box G-E537, Providence, RI, 02912. Phone: 401-863-6508. Fax: 401-863-9008. Email: carmen_marsit{at}brown.edu

Head and neck squamous cell carcinomas (HNSCC) represent clinically and etiologically heterogeneous tumors affecting over 40,000 patients per year in the United States. Previous research has identified individual epigenetic alterations, and, in some cases, the relationship of these alterations with carcinogen exposure or patient outcomes, suggesting that specific exposures give rise to specific types of molecular alterations in HNSCCs. Here we describe how different etiologic factors are reflected in the molecular character and clinical outcome of these tumors. In a case series of primary, incident HNSCC (n = 68), we examined the DNA methylation profile of 1413 autosomal CpG loci in 773 genes, in relation to exposures and etiologic factors. The overall pattern of epigenetic alteration could significantly distinguish tumor from normal head and neck epithelial tissues (P<0.0001) more effectively than specific gene methylation events. Amongst tumors there were significant associations between specific DNA methylation profile classes and tobacco smoking and alcohol exposures. Although there was a significant association between methylation profile and tumor stage (P<0.01), we did not observe an association between these profiles and overall patient survival after adjustment for stage, although, methylation of a number of specific loci falling in different cellular pathways were associated with overall patient survival. We found that the etiologic heterogeneity of HNSCC is reflected in specific patterns of molecular epigenetic alterations within the tumors, and that the DNA methylation profiles may hold clinical promise worthy of further study.


* These authors contributed equally to this work

Received October 8, 2008; revised November 24, 2008; accepted December 22, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.